Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients

    NEXT STORY
    Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors
    PREV STORY
    Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immune Design Announces G100’s Receipt of Orphan Drug Designation by the EMA for the Treatment of Follicular Non-Hodgkin’s Lymphoma

    SEATTLE and SOUTH SAN FRANCISCO, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Immune Design ...

    author_avatar
    NASDAQ Market News

    Beta Bionics and Zealand Pharma announce superior glycemic control in Phase 2 home-use clinical trial testing the iLet™ bionic pancreas using dasiglucagion

    author_avatar
    NASDAQ Market News

    The Board of Oasmia has decided to report certain transactions to the Swedish Economic Crime Authority and to appoint a special examiner

    author_avatar
    NASDAQ Market News